IDH1 and astrocytoma (excluding glioblastoma): The presence of diagnostic markers, such as 1p/19q codeletion or the loss of expression of ATRX and TP53 tumor suppressors, aids in defining the diagnoses of oligodendroglioma or IDH-mutant astrocytoma, respectively.